Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tang

Showing results (601-610 of 619) with videos related to

Pageof 62
Sort By:
Nature Protocols|January 27, 2017
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimensXuefeng Liu, Ewa Krawczyk, Frank A Suprynowicz, et al.
Human & Experimental Toxicology|November 27, 2013
Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicinM Pacifico de Freitas Segredo, D M Favero Salvadori, N S Rocha, et al.
Science Advances|October 11, 2024
Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activityTing Fan, Congcong Xu, Jichuan Wu, et al.
Nature Communications|September 8, 2018
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responsesQiuhui Li, Qu Deng, Hsueh-Ping Chao, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient SurvivalXiaozhuo Liu, Eduardo Cortes, Yibing Ji, et al.
Frontiers in Cardiovascular Medicine|March 28, 2024
Contemporary approach to cardiogenic shock care: a state-of-the-art reviewAditya Mehta, Ilan Vavilin, Andrew H Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)A Fernandez-Martinez, M Tanioka, S G Ahn, et al.
JAMA Cardiology|January 31, 2024
Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support: The STOP-RVF ScoreIosif Taleb, Christos P Kyriakopoulos, Robyn Fong, et al.
Annals of the New York Academy of Sciences|December 1, 2021
Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia reportJennifer Cable, Duanqing Pei, Lola M Reid, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
Pageof 62

Showing results (601-610 of 619) with videos related to

Sort By:
Pageof 62
Nature Protocols|January 27, 2017
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimensXuefeng Liu, Ewa Krawczyk, Frank A Suprynowicz, et al.
Human & Experimental Toxicology|November 27, 2013
Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicinM Pacifico de Freitas Segredo, D M Favero Salvadori, N S Rocha, et al.
Science Advances|October 11, 2024
Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activityTing Fan, Congcong Xu, Jichuan Wu, et al.
Nature Communications|September 8, 2018
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responsesQiuhui Li, Qu Deng, Hsueh-Ping Chao, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient SurvivalXiaozhuo Liu, Eduardo Cortes, Yibing Ji, et al.
Frontiers in Cardiovascular Medicine|March 28, 2024
Contemporary approach to cardiogenic shock care: a state-of-the-art reviewAditya Mehta, Ilan Vavilin, Andrew H Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)A Fernandez-Martinez, M Tanioka, S G Ahn, et al.
JAMA Cardiology|January 31, 2024
Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support: The STOP-RVF ScoreIosif Taleb, Christos P Kyriakopoulos, Robyn Fong, et al.
Annals of the New York Academy of Sciences|December 1, 2021
Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia reportJennifer Cable, Duanqing Pei, Lola M Reid, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
Pageof 62